Gaudium IVF applies artificial intelligence to improve precision in infertility treatment

Dr Manika Khanna, Chairperson and Managing Director, Gaudium IVF, and Giles Palmer, Director, IVF 2.0, highlight precision led IVF processes and improved clinical decision making

Mumbai, April 2, 2026: Gaudium IVF has integrated artificial intelligence into infertility treatment, introducing advanced embryology systems into routine clinical practice.
The development includes the use of AI driven tools such as SiD, a sperm identification system, and ERICA, an embryo ranking platform, aimed at improving precision during key stages of the IVF process.
The initiative was inaugurated by Nitin Jairam Gadkari, Union Minister for Road Transport and Highways, Government of India, who highlighted the role of advanced technologies in driving innovation across sectors.

The integration has been undertaken in collaboration with IVF 2.0, a UK based embryology innovation organisation founded by Jacques Cohen and Alejandro Chave, bringing global embryology expertise into the Indian clinical ecosystem.
Dr Manika Khanna, Chairperson and Managing Director, Gaudium IVF, said, “Fertility care is evolving towards precision led outcomes. The integration of AI allows for greater consistency, transparency, and improved decision making in the treatment process.”

SiD analyses sperm movement parameters to identify viable candidates for fertilisation, while ERICA evaluates embryo quality using image based analysis of developmental characteristics. These non invasive tools assist embryologists in making more consistent and data driven decisions.
Giles Palmer, Clinical Scientist and Director of Global Communications, IVF 2.0, said the collaboration enables the application of embryology intelligence in clinical settings, supporting measurable improvements in outcomes.

Early observations indicate that AI integration can improve fertilisation rates and blastocyst development, while potentially reducing the need for repeat treatment cycles. This may help lower the emotional and financial burden on patients.
Gaudium IVF, which recently became India’s first publicly listed IVF chain, continues to focus on technology driven approaches in reproductive healthcare, with a growing presence across India.

At Prittle PrattleNews, featuring you virtuously, we celebrate the commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.